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To determine the live birth and cumulative live birth rates of expected poor ovarian respond-







A total of 1,152 subfertile women undergoing their first in vitro fertilization (IVF) cycle
Interventions
Women were classified into 4 groups according to the Bologna criteria for comparison
Main OutcomeMeasure(s)
Live birth and cumulative live birth rates
Results
Women with expected poor response (POR) had the lowest live birth rate than the other 3
groups (23.8%, p = 0.031). Cumulative live birth rates were significantly lower in those with
expected POR than those with expected normal ovarian response (NOR) (35.8% vs 62.8%,
p<0.0001). In the subgroup analysis, the cumulative live birth rates in expected PORs were
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significantly lower in those who had3 oocytes retrieved (18.6% for3 oocytes vs 44.0%
for>3 oocytes, p = 0.006) whereas the live birth rates in fresh cycle did not differ (17.8% vs
30.9%, p = 0.108).
Conclusion
Women who were expected POR according to the Bologna criteria had lower live birth and
cumulative live birth than expected NOR but they still can achieve reasonable treatment out-
comes and IVF treatment should not be precluded.
Introduction
The success of in-vitro fertilization (IVF) depends on an adequate follicle recruitment by using
ovarian stimulation with gonadotrophins. Unfortunately early reports suggest that the inci-
dence of poor ovarian response (POR) ranges from 9% to 24% in women undergoing ovarian
stimulation for IVF [1]. POR remains one of the main therapeutic challenges in modern repro-
ductive medicine and despite many strategies have been proposed for the management of this
particular cohort of women, none is considered to be unequivocally effective [2–3].
One of the limitations in interpreting the relevant literature is the huge discrepancy in the
definitions used for POR [4]. The European Society of Human Reproduction and Embryology
(ESHRE) made the first attempt in 2011 to reach a consensus on the definition of POR (the Bo-
logna criteria) with the aim to characterize this condition in a simplified and reproducible ap-
proach [5]. According to the Bologna criteria, the minimal criteria needed to define POR are
the presence of at least two of the following three features: [i] advanced maternal age (40
years) or any other risk factors for POR; [ii] a previous POR (3 oocytes with a conventional
stimulation protocol); and [iii] an abnormal ovarian reserve test. A recent retrospective study
reported for the first time an overall low live birth rate of 6% per cycle in Bologna poor re-
sponders irrespective of age and treatment protocol used [6].
In a realistic approach, the term POR should refer to the ovarian response and therefore,
one stimulated cycle is considered essential for the diagnosis of POR. However, the trend of de-
laying first pregnancies has led many women to present to their first IVF treatment at an ad-
vanced age. Aging results in a physiological decline in the ovarian follicle pool and the
prevalence of POR is known to increase with age [5]. Ovarian reserve tests (ORT) help to pro-
vide an indirect measure of the primordial follicle pool and among all the tests, antral follicle
count (AFC) and anti-Mullerian hormone (AMH) are considered as the most reliable and ac-
curate markers of ovarian reserve and have the best sensitivity and specificity for predicting
ovarian response [7–8]. Therefore, women over 40 years of age with an abnormal ORT may be
classified as poor responders since both advanced age and an abnormal ORT may indicate re-
duce ovarian reserve and act as a surrogate of ovarian stimulation cycle. In this case, the
women should be more properly defined as expected PORs [5]. The precognition of the preg-
nancy potential in this group of expected PORs can help clinicians to provide important
counseling information to women and avoid unnecessary financial burden and disappointing
outcome of IVF treatment. To date no data are available regarding live birth and cumulative
live birth rates in expected PORs according to the Bologna criteria.
The purposes of the present study were (i) to explore the live birth and cumulative live birth
rates for Bologna expected poor ovarian responders undergoing first cycle of IVF treatment;
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and (ii) to compare the results with those with expected normal ovarian response and those
with poor ovarian reserve (either age40 years or abnormal ovarian reserve test) alone.
Materials and Methods
This was a retrospective study carried out at the Centre of Assisted Reproduction and Embryol-
ogy, The University of Hong Kong—Queen Mary Hospital, Hong Kong. Clinical details of all
treatment cycles were prospectively entered into a computerized database, which were checked
for accuracy and completeness on a regular basis and were retrieved for analysis. Ethical ap-
proval was obtained from the Institutional Review Board of the University of Hong Kong/Hos-
pital Authority Hong Kong West Cluster for this retrospective study. Written informed
consent was obtained from women for the use of their clinical records.
Study Population
We analyzed data of subfertile women who underwent first IVF/intracytoplasmic sperm injec-
tion (ICSI) cycles between January 2007 and December 2009. Women with incomplete records
and cycles carried out for pre-implantation genetic diagnosis or those using donor oocytes
were excluded.
Women were divided into four groups for comparison: (i) Expected normal ovarian re-
sponse (ENOR); (ii) Expected poor ovarian response (EPOR); (iii) Bologna 1; (iv) Bologna 3.
ENOR was those aged<40 with normal ORT and no history of ovarian surgery/endome-
trioma. EPOR was defined according to the Bologna criteria as women with advanced maternal
age (40 years) or history of ovarian surgery/endometrioma together with an abnormal ORT.
Bologna 1 referred to those women aged40 or had history of ovarian surgery/endometrioma
but normal ORT while Bologna 3 referred to those aged< 40 and no history of ovarian sur-
gery/endometrioma but had an abnormal ORT.
Determination of abnormal ORT
The ESHRE consensus group defined abnormal ORT as AFC of<5–7 or AMH of<0.5–1.1 ng/ml
[5] based on previous systematic reviews [7, 9]. The ability of AFC and AMH to predict a yield
of three oocytes or less (as suggested by the Bologna criteria) with a conventional stimulation
protocol (as detailed below) was assessed by receiver operator characteristic (ROC) curve anal-
ysis using the data of this particular cohort of eligible women once stimulation was performed.
These gave areas under the curve (AUC) values of 0.77 for AFC (95% confidence interval
0.75–0.80, p<0.0001) and 0.80 for AMH (95% confidence interval 0.78–0.83, p<0.0001). The
optimum cut-off value for AFC was6 (sensitivity of 69% and specificity of 74%) and for
AMH was2 ng/ml (sensitivity of 78% and specificity of 71%), and these values were used to
define abnormal ORT in our cohort.
Ovarian stimulation and embryo transfer
Details of the stimulation cycle have been previously reported [10]. All women were treated ei-
ther with the long GnRH agonist protocol or the GnRH antagonist protocol for pituitary
down-regulation. The initial dose of stimulation was determined according to the baseline
AFC (AFC15: 150 IU per day; AFC between 6–14: 300 IU for the first two days followed by
150 IU daily; AFC5: 450 IU for the first two days followed by 225 IU daily). Cycles would be
cancelled if no follicular growth was observed after 14 days of maximum stimulation. Human
chorionic gonadotrophin was given to trigger the final oocyte maturation when at least one
leading follicle reached 18 mm in diameter. Fertilization was carried out in vitro either by
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conventional insemination or ICSI depending on semen parameters. Fresh embryo transfer
(ET) was carried out with replacement of at most two embryos of the best quality available two
days after retrieval. Excess good quality embryos were also cryopreserved on the day of ET.
Pregnancies were confirmed by positive urine hCG tests and transvaginal ultrasonographic evi-
dence of a gestational sac.
Cryopreservation and frozen-thawed embryo transfer
The details of the freezing and thawing protocols were reported previously [11]. The frozen
embryos were thawed on the morning of FET. Embryos were discarded if more than 50% of
original blastomeres were lysed or degenerated upon thawing. Frozen-thawed embryos were
transferred in natural cycles in ovulatory women, or in either clomiphene-induced or hormone
replacement cycles for anovulatory women. A maximum of two frozen embryos were allowed
to be transferred in any one FET cycle.
Collection of clinical information
Clinical information including age, body mass index, basal serum levels of AMH, and AFC
were collected. Cycle characteristics such as days of stimulation, total dosage of gonadotrophin,
number of oocytes retrieved, and number of transferrable embryos, and cycle cancellation rate
due to poor response were recorded.
Clinical pregnancy was defined as the presence of a gestational sac by ultrasonography,
whereas miscarriage rate per clinical pregnancy was defined as the proportion of patients who
failed to continue development to 20 weeks of gestation in all clinical pregnancies. Pregnancy
outcome was collected from all pregnant women by postal questionnaire or by phone. Live
birth was defined as the delivery of a fetus with signs of life after 24 completed weeks of
gestational age.
Main outcome measures
The main outcome measures were live birth and one-cycle cumulative live birth rates. Only
women who completed replacement of all available frozen embryos were included for analysis
of the cumulative live birth rate. In addition, within the group of EPOR, live birth and cumula-
tive live birth rates were analyzed according to the number of oocytes retrieved at the threshold
of three (3 and>3 oocytes retrieved), since this threshold is one of the Bologna criteria.
Statistical analysis
For each group of women, categorical data are presented by number of cases and percentages.
Continuous data are presented as median with interquartile range. Statistical analysis was per-
formed using Mann-Whitney test, Kruskal-Wallis test or Student’s t test, as appropriate. The
chi-squared test and Fisher’s exact test were used for the comparisons of categorical variables.
Statistical analysis was carried out using the Statistical Program for Social Sciences (SPSS Inc.,
Version 20.0, Chicago, USA). The two-tailed value of P<0.05 was considered statistically
significant.
Results
A total of 1,156 women underwent the first IVF cycle during the study period and four were ex-
cluded because of incomplete data. The prevalence of ENOR and EPOR among them was
48.8% (562/1152) and 13.9% (160/1152) respectively. Eighty-two of them (7.1%) fulfilled Bolo-
gna criteria 1 alone and 348 (30.2%) fulfilled Bologna criteria 3 alone.
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The baseline characteristics were presented in Table 1. The age and the type of subfertility
were comparable among the 4 different groups. AMH and AFC values, as expected, were sig-
nificantly lower in EPOR women and women with abnormal ORT alone (Bologna 3) when
compared with ENOR women. Male factor was the commonest cause of subfertility among the
4 groups, but the prevalence was significantly higher in ENOR group and Bologna 3 group.
The cycle characteristics and reproductive outcomes were shown in Table 2. Women who
were EPOR required significantly longer duration of stimulation and higher dosage of gonado-
trophin, and they had significantly lower number of oocytes retrieved and number of
Table 1. Patients’ baseline characteristics.
ENOR (N = 562) EPOR (N = 160) Bologna 1 (N = 82) Bologna 3 (N = 348) P value
Age (years) 34 (32–37) 38 (35–41) 36 (33–40) 37 (34–38) NS
Body mass index (kg/m2) 21.3 (19.6–23.2) 21.0 (19.4–22.7) 20.9 (19.6–23.1) 21.2 (19.6–23.2) <0.001
AMH (ng/ml) 4.94 (3.50–7.63) 1.05 (0.54–1.70) 3.75 (2.78–5.82) 1.33 (0.87–1.86) <0.001
AFC 14 (10–18) 5 (3–6) 11 (9–13) 5 (4–7) <0.001
Duration of subfertility (years) 4 (3–6) 3 (2–5) 4 (3–6) 4 (3–6) <0.001
Primary subfertility 379 (67.4) 107 (66.9) 56 (68.3) 229 (65.8) NS
Secondary subfertility 183 (32.6) 53 (33.1) 26 (31.7) 119 (34.2) NS
Cause of subfertility <0.001
Male factor 366 (65.1) 63 (39.4) 36 (43.9) 219 (62.9)
Tuboperitoneal factor 79 (14.1) 25 (15.6) 8 (9.8) 47 (13.5)
Endometriosis 12 (2.1) 23 (14.4) 11 (13.4) 8 (2.3)
Unexplained 79 (4.1) 39 (24.4) 20 (24.4) 58 (16.7)
Anovulation 26 (4.6) 10 (6.2) 7 (8.5) 16 (4.6)
Data expressed as median (interquartile range) or number (%)
doi:10.1371/journal.pone.0119149.t001
Table 2. Cycle characteristics and reproductive outcomes.
ENOR (N = 562) EPOR (N = 160) Bologna 1 (N = 82) Bologna 3 (N = 348) P value
Duration of stimulation (days) 11 (9–12) 11 (10–13) 11 (9–12) 12 (10–13) <0.001
Total dose of gonadotrophin (IU) 1800 (1500–2400) 3150 (2700–3600) 1950 (1650–2700) 2850 (2438–3375) <0.001
Peak E2 (pmol/L) 12343 (8375–18388) 5682 (4145–10262) 11508 (8061–17164) 7279 (4229–11334) <0.001
Number of eggs retrieved 11 (8–15) 5 (3–8) 11 (8–13) 6 (4–9) <0.001
Number of transferrable embryos 5 (3–8) 2 (1–4) 5 (2–7) 3 (2–5) <0.001
Cycle cancellation due to poor response 0 (0) 1 (0.6) 0 (0) 1 (0.3) NS
Patients with 3 oocytes retrieved 26 (4.6) 51 (31.9) 2 (2.4) 78 (22.4) <0.001
Clinical pregnancy 259 (46.1) 53 (33.1) 37 (45.1) 144 (41.4) 0.02a
Miscarriage 57/259 (22.0) 15/53 (28.3) 7/37 (18.9) 31/144 (21.5) NS
Live birth 202 (35.9) 38 (23.8) 30 (36.6) 113 (32.5) 0.031b
Cumulative live birth 323/514 (62.8) 48/134 (35.8) 41/76 (53.9) 146/314 (46.5) <0.0001c
Data expressed as median (interquartile range), n(%) or n/total (%)
aClinical pregnancy rate was signiﬁcantly lower in EPOR than ENOR group
bLive birth rate was signiﬁcantly lower in EPOR than the other 3 groups
cCumulative live birth rate was signiﬁcantly lower in EPOR than the other 3 groups. Bologna 3 group had signiﬁcantly lower cumulative live birth rate than
ENOR.
doi:10.1371/journal.pone.0119149.t002
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transferrable embryos. Only one patient had cycle cancellation. The median number of oocytes
retrieved in EPOR group was 5 and 31.9% of them had 3 or less oocytes retrieved. The live
birth rates per started cycle were 35.9% and 23.8% for ENOR and EPOR respectively (p =
0.004). For those fulfilling Bologna 1 or Bologna 3 alone, the live birth rates per started cycle
were comparable with ENOR (36.6% in Bologna 1 vs 35.9% in ENOR, p = 0.90; 32.5% in Bolo-
gna 3 vs 35.9% in ENOR, p = 0.31) but significantly higher than EPOR (36.6% in Bologna 1 vs
23.8% in EPOR, p = 0.05; 32.5% in Bologna 3 vs 23.8% in EPOR, p = 0.05).
Overall, 1,038 women completed replacement of all available frozen embryos. The cumula-
tive live birth rate of EPOR group was significantly lower than ENOR group (35.8% vs 62.8%,
p<0.0001). Those fulfilling Bologna 1 had similar cumulative live birth rate to ENOR (53.9%
vs 62.8%, p = 0.16) but higher than EPOR (p = 0.01). Those fulfilling Bologna 3 had significant-
ly lower cumulative live birth rate than ENOR (46.5% vs 62.8%, p<0.0001) but higher than
EPOR (p = 0.04).
In the EPOR group, 142 out of 160 women had fresh embryo transfer and 134 had complet-
ed transfer of all available embryos. Further analysis according to ovarian response showed
that the live birth rates in EPOR did not significantly differ between poor response (3 oocytes
retrieved) and normal response (>3 oocytes retrieved) as shown in Table 3. However, for those
with have>3 oocytes retrieved, the cumulative live birth rate was significantly higher (44.0%
vs 18.6%, p = 0.006). When comparing the 134 who had completed transfer of all available em-
bryos, women aged<40 with history of ovarian surgery/endometrioma and abnormal ORT
performed better than those with advanced age40 and abnormal ORT in terms of cumulative
live birth rates (46.4% (39/84) vs 18.0% (9/50), p<0.001). In Bologna 3 the live birth rates also
did not significantly differ between poor response and normal response (36.1% vs 34.9%), but
for those with have>3 oocytes retrieved, the cumulative live birth rate was significantly higher
(49.4% vs 34.9%, p = 0.048) (Table 4).
Multivariable logistic regression analysis revealed that age and number of embryos replaced
were significantly associated with the live birth rate with OR 0.87 (95% CI 0.83–0.92) and OR
4.13 (95% CI 2.05–8.28) respectively, after adjusting for other characteristics including EPOR/
ENOR classification, AFC, AMH, and body mass index. Likewise, age and total number of
transferrable embryos were significant independent predictors of cumulative live birth rates
with OR 0.87 (95% CI 0.82–0.92) and OR 1.32 (1.23–1.41) respectively.
Table 3. Reproductive outcomes in EPOR by ovarian response.
> 3 oocytes retrieved  3 oocytes retrieved P value
Live birth in fresh cycle 30/97 (30.9%) 8/45 (17.8%) NS
Cumulative live birth 40/91 (44.0%) 8/43 (18.6%) 0.006
doi:10.1371/journal.pone.0119149.t003
Table 4. Reproductive outcomes in subjects fulﬁlling Bologna criteria 3 only stratiﬁed by ovarian
response.
> 3 oocytes retrieved  3 oocytes retrieved P value
Live birth in fresh cycle 91/252 (36.1%) 22/63 (34.9%) NS
Cumulative live birth 124/251 (49.4%) 22/63 (34.9%) 0.048
doi:10.1371/journal.pone.0119149.t004
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Discussion
The aim of this study was to examine the implications of expected poor ovarian response as de-
fined by the Bologna criteria for women undergoing their first IVF/ICSI treatment, in particu-
lar live birth and cumulative live birth rates, which are the most relevant information for
women and their clinicians. Our results showed that EPOR were not uncommon among
women pursuing IVF/ICSI treatment (13.9%) and it highlighted the poorer prognosis of EPOR
in terms of reproductive outcomes when compared to ENOR, but nonetheless they achieved
live birth and cumulative live birth rates of 23.8% and 35.8% respectively. Multivariate logistic
regression model revealed that EPOR/ENOR was not a significant predictor of live birth or cu-
mulative live birth after adjusting for age, AFC, AMH, body mass index and number of embry-
os transferred in the fresh cycle / total number of transferrable embryos. Only age and number
of embryos were significant predictors of such outcome.
The prevalence of poor ovarian responders varies depending on the definitions of poor re-
sponse. In general, poor ovarian responders (who did not meet the Bologna criteria) are re-
ported to have low pregnancy rate and low live birth rate [12–13]. The ESHRE group made the
attempt to standardize the definition of poor responders in 2011 and subsequent studies have
consistently showed low live birth rates of 7.4–9.9% following natural cycle IVF and stimulated
IVF in Bologna poor responders [6, 14]. Another study has demonstrated cumulative live birth
rate of 12.7%–20.5% after three cycles of ovarian stimulation IVF [15]. Our live birth and cu-
mulative live birth rates, in contrast to previous studies, were more optimistic at 23.8% and
35.8% respectively. This discrepancy is likely attributed to the difference in selection of patients
as all the previous studies included women with one or more previous cycles with POR whereas
we only included expected POR based on their age/risk factors for POR and results of ovarian
reserve test. Women with previous POR to ovarian stimulation are more likely to have a recur-
rence of a poor response [16], and the pregnancy rate is decreased in the subsequent cycles if
abnormal ORTs are present [17].
The median number of oocytes retrieved in Polyzos’s retrospective study [6] was 3 as com-
pared to 5 in our study. Pregnancy prospects reduce when fewer oocytes are retrieved [18] and
an increase in the number of oocytes is an independent variable related to live birth rates [6].
Despite only 31.9% of EPOR women had3 oocytes retrieved, our results were consistent in
showing that these women had a poorer prognosis in terms of cumulative live birth rates than
those who have>3 oocytes retrieved. This confirms that the threshold of 3 oocytes adopted by
the ESHRE consensus is adequate to identify women with the poorer prognosis in terms of cu-
mulative live birth rates. Interestingly, within the EPOR women, those with advanced age to-
gether with abnormal ORT did poorer than those aged<40 with risk factor for POR and
abnormal ORT, reflecting age alone remains the best marker of oocyte quality and the best sin-
gle predictor of ongoing pregnancy.
The risk of POR generally increases with age [5] and in women with endometriomas with
or without cystectomies [19], but their ovarian reserve may still vary and are better assessed by
ORTs. Our data suggested that women with Bologna 1 alone had significantly better ovarian
response and reproductive outcomes compared with expected POR as defined by the Bologna
criteria, possibly related to the better ovarian reserve as reflected by the significantly higher
AFC and AMH level. Bologna 1 alone is the less strong in the prediction of POR as only 2.4%
of women with Bologna 1 were actually poor responders with3 oocytes retrieved. However,
our women with Bologna 3, albeit similar ovarian reserve to EPOR women, achieved signifi-
cantly higher live birth and cumulative live birth. This is in concordance with our previous
study which showed women aged less than 40 with extremely low levels of AMH could still
achieve a reasonable live birth rate [20]. Only 22.4% of women with Bologna 3 alone had
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actually a poor response, and of those with poor response their live birth rates were actually
similar to those with better response. Our results highlighted that a single criterion is insuffi-
ciently accurate to identify those with poor prognosis, and even new markers like AMH used
alone still fail to adequately identify women with the highest probability of being a real POR.
Our study is limited by its retrospective design and therefore there were several baseline
characteristics that significantly differed among the groups. In the study design we defined Bo-
logna 1 based on the women’s age, presence of endometrioma and ovarian cystectomy, as these
were the easily identifiable risk factors. However, our study failed to address other risk factors
for POR including any genetic or acquire conditions possibly linked to a reduced ovarian re-
serve, as criticized by some authors [21]. It is possible to suspect that an even lower (cumula-
tive) live birth rates in EPOR women who had other identified risk factors. The limitations of
AMH assays, particularly with regard to assay bias, should also be taken into account. The
AMH cut-off that we used in this study was higher than that suggested by the original Bologna
consensus paper [5]. This could be due to the different AMH assays used: the Gen II ELISA kit
by Beckman-Coulter was used in this study whereas older assay methods were used in most
previous publications reviewed by the Bologna consensus paper [5]. The initial dose of stimula-
tion was determined according to the baseline AFC alone as per department protocol and
AMH levels were not taken into account. This could potentially introduce bias as AMH was
used as one of the criteria of ORT in classifying women. In addition, our results may not be ap-
plicable to other IVF centers as treatment protocols can be different and performance of
women can vary among centers. We had a lower cycle cancellation rate of 0.002% (2/1,152)
when compared to other studies [22], likely related to our lower threshold for cycle cancellation
as we only cancelled the cycle when there was no response whereas other centers usually can-
celled the cycle when<3 follicles of size 18 mm were recruited in response to gonadotrophins.
Despite using the Bologna criteria as suggested by the ESHRE group which aimed to estab-
lish ‘minimal criteria’ to select a homogeneous population of women in terms of oocytes quan-
tity, our results in terms of reproductive outcomes were significantly different from Polyzos
group due to the reasons stated above [6]. They demonstrated a very low live birth rates in Bo-
logna poor responders and suggested some of the women fulfilling the criteria should be con-
sidered as potential candidates for oocyte donation programmes. Our results, in contrary,
showed reasonable live birth and cumulative live birth rates in expected POR and these women
should not be precluded from IVF programmes. This observed difference reinforced the fact
that reproductive outcomes can vary widely depending on the criterions used, and the applica-
bility of these criteria is subjected for reevaluation in the future [4]. Further prospective re-
searches are required to determine the actual reproductive potential of Bologna poor
responders in IVF treatment, preferably with reference to the criterions used. Nonetheless our
results provide valuable information to women who anticipate their first IVF treatment and
this is of paramount importance during pre-treatment counseling.
In conclusion, our retrospective data, for the first time, suggested that women who were ex-
pected POR according to the Bologna criteria had poorer prognosis in terms of (cumulative)
live birth than expected NOR but they still can achieve reasonable treatment outcomes and
should not be precluded from attempting IVF.
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